Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans
Year: 1989
Type: article
Study design: Clinical Trial
Source: Cancer Immunology Immunotherapy
DOI: 10.1007/bf01669422
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funder: National Cancer Institute
Award: G6903124011
OpenAlex ID: W1997927810